Results 41 to 50 of about 7,848 (213)

Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States

Mycoses, Volume 68, Issue 9, September 2025.
ABSTRACT Background Rezafungin, a novel echinocandin with once‐weekly intravenous dosing, offers potential advantages for outpatient parenteral antifungal therapy (OPAT) in invasive candidiasis (IC). While clinical trial data support its efficacy and safety, real‐world experience remains limited.
Ilana Reinhold, Giovanni Mori, Massimiliano Lanzafame, Alessandro Limongelli, Antonio Vena, Julia Götz, Stilla Bauernfeind, Frank Hanses, Lukas Tometten, Michael Mayer, Ansgar Rieke, Ana Soriano‐Martin, Maricela Valerio, Jose A. Vazquez, Patrick Yue, Laman Rahimli, Nijat Azimli, Ertan Sal, Jon Salmanton‐García, Natalia Vasenda, Rosanne Sprute, Jannik Stemler, Sebastian Wingen‐Heimann, Oliver A. Cornely, Danila Seidel   +24 more
wiley   +1 more source

Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease.
Suengwon Lee, Robert J. Levy, Abigail J. Christian, Stanley L. Hazen, Nathan E. Frick, Eric K. Lai, Juan B. Grau, Joseph E. Bavaria, Giovanni Ferrari   +8 more
doaj   +1 more source

Chronic kidney disease and valvular heart disease: State of the art

Physiological Reports, Volume 13, Issue 18, September 2025.
Abstract Chronic kidney disease (CKD) and valvular heart disease (VHD) frequently coexist and are associated with a significant increase in morbidity and mortality. Their interplay is complex and multifactorial, involving shared pathophysiological mechanisms such as chronic inflammation, mineral and bone disorder, vascular and valvular calcification ...
S. Saltarocchi, M. D'Abramo, P. De Orchi, F. Spunticchia, M. Totaro, E. M. Cirio, F. Miraldi   +6 more
wiley   +1 more source

A Case Series of Valve‐in‐Valve Transcatheter Aortic Valve Replacement in Stentless Bioprosthetic Valves Using Self‐Expanding Platform With Minimalist Approach

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 992-1001, August 1, 2025.
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan, Raj Rajendra, Elved Roberts, Jan Kovac   +3 more
wiley   +1 more source

Early calcific degeneration of the St. Jude Medical Epic aortic bioprosthesis

Clinical Case Reports, 2020
This report highlights the need for close surveillance of bioprosthetic valves. Unaccountable degeneration of bioprosthetic valves can develop early after implantation and usually requires replacing the failed valve with a mechanical prosthesis.
Mohammad Bashar Izzat, Nada Sabbagh, Hazem Aljasem   +2 more
doaj   +1 more source

Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective

Brazilian Journal of Cardiovascular Surgery, 2021
Introduction: The increase in the prevalence of aortic stenosis due to an aging population has led to an increasing number of surgical aortic valve replacements.
Tiago R Velho, Rafael Maniés Pereira, Frederico Fernandes, Nuno Carvalho Guerra, Ricardo Ferreira, Ângelo Nobre   +5 more
doaj   +1 more source

Bioprosthetic Valve Fracturing in Valve‐in‐Valve TAVI: Clinical and Echocardiographic Outcomes in Failing Perimount Aortic Bioprostheses—A Multicenter Registry

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 1409-1420, August 1, 2025.
ABSTRACT Background Data comparing clinical and hemodynamic outcomes of bioprosthetic valve fracturing (BVF) and “standard”‐postdilatation during valve‐in‐valve transcatheter heart valve implantation (ViV‐TAVI) are lacking. The authors aimed to analyze hemodynamic and clinical outcomes of BVF compared to “standard”‐postdilatation during ViV‐TAVI ...
Hendrik Ruge, Melchior Burri, Julia Schreyer, Teodora‐Cristiana Georgescu, Derk Frank, Won‐Keun Kim, Ole de Backer, Martin Beyer, Andreas Schäfer, Chiara Fraccaro, Giuseppe Tarantini, Erion Xhepa, Michael Joner, Markus Krane, Héctor Alfonso Alvarez Covarrubias   +14 more
wiley   +1 more source

Abdominal wall repair with acellular bovine pericardial membranes - Part I - Clinical and radiological findings [PDF]

Revista Brasileira de Cirurgia Plástica
Introduction: Reducing recurrence rates significantly, the use of biomaterials as “reinforcement meshes” in the repair of different abdominal wall defects has become an almost mandatory routine for the success of these repairs.
Luiz Fernando Frascino, Fernanda Ribeiro Funes Lorenzzato, Hamilton Luiz Funes, Jonas Dias de Campos Severi   +3 more
doaj   +1 more source

The International TrifectaTM and EpicTM Valve‐in‐Valve Registry: Insights Into Clinical & Hemodynamic Outcomes

Catheterization and Cardiovascular Interventions, Volume 105, Issue 7, Page 1711-1718, June 1, 2025.
ABSTRACT Background Little is known about the clinical and hemodynamic outcome of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR) for failed Trifecta surgical aortic bioprotheses. Aims We aimed to compare outcomes of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR into failed TrifectaTM vs.
Matthias Raschpichler, Mohamed Abdel‐Wahab, Nick Curzen, Manuel Wilbring, Christoph Dubois, Kayan Lam, Gloria Faerber, Jana Nagel, Holger Thiele, Michael A. Borger   +9 more
wiley   +1 more source

Pregnancy outcomes in women with a mitral valve prosthesis: A systematic review and meta-analysisCentral MessagePerspective

JTCVS Open, 2023
Objectives: To evaluate the ongoing debate concerning the choice of valve prosthesis for women requiring mitral valve replacement (MVR) and who wish to conceive. Bioprostheses are associated with risk of early structural valve deterioration.
Pepijn Grashuis, BSc, Shanti D.M. Khargi, BSc, Kevin Veen, BSc, PhD, Azzeddine el Osrouti, BSc, Shirin Bemelmans-Lalezari, MD, PhD, Jérôme M.J. Cornette, MD, PhD, Jolien W. Roos-Hesselink, MD, PhD, Johanna J.M. Takkenberg, MD, PhD, Mostafa M. Mokhles, MD, PhD   +8 more
doaj   +1 more source